RE: Clear statement of intent13 Oct 2021 21:08
To me that RNS means that Eli Lilly is the ultimate winner. If product fails, they have cash from IP. If product wins, HEMO will be a milking cow for them at huge scale. HEMO gets to work hard for success, but what about us, Stakeholders? Will there be left enough for us (dividends)?
One thing is for sure regardless of the outcome, the number of people suffering from cancer is growing exponentially. Having Eli Lilly as a bodyguard (Yeap, they will pave the path for this treatment if there is a nest with golden eggs lying there) of this investment is a good sign.